Lab Manager | Run Your Lab Like a Business

Immune System Promotes Digestive Health by Fostering Community of “Good” Gut Bacteria

As many as 1.4 million Americans suffer from uncomfortable abdominal cramping and diarrhea that come with ulcerative colitis and Crohn’s disease. These conditions, collectively known as inflammatory bowel disease (IBD), are associated with an imbalance among the thousands of species of “good” bacteria that inhabit the gut. A University of Utah study published on Jan. 22, 2015, in Cell Host and Microbe demonstrates that mice deficient for a component of the immune system, a protein called MyD88, have an imbalanced gut bacterial community – with some species dominating over others - and are more susceptible to contracting a severe IBD-like illness. Further, fecal transplants from healthy donors alleviate IBD symptoms in these mice.

by University of Utah Health Care
Register for free to listen to this article
Listen with Speechify
0:00
5:00

immune system and healthy bacteria(Left) When the immune system functions properly (MyD88 is active, green), IgA antibodies bind multiple species of bacteria, keeping the numbers and types of “good” bacteria that inhabit the gut under control. (Right) When the immune system is disrupted (MyD88 is inactive, gray), IgA binds bacteria less effectively, and the bacterial community becomes imbalanced, jeopardizing digestive health.University of Utah School of MedicineThe results show that the immune system encourages growth of a healthy community of “good” bacteria that is important for digestive health. This perspective on immune system function is in contrast to it’s best-known role as the first line of defense in the fight against pathogens, including invasive bacteria.

“Our work highlights that the immune system shapes the composition of bacterial communities in the intestine,” says senior author June Round, Ph.D., assistant professor of pathology at the University of Utah School of Medicine. “This interaction is important because it’s becoming more and more clear that resident microbes are very important for our health.”

Considering that some people with IBD have mutations in genes that are part of a MyD88-controlled pathway, fecal transplantation - which involves collecting and processing stool from a healthy donor, and delivering it into a recipient’s gut - might help to ameliorate disease in these people, according to Round.

Loss of MyD88 disturbs the microbial community because it disrupts production of IgA. This class of antibody works like a gatekeeper that controls which types of bacteria, and how many, are allowed to inhabit the gut. By performing inventories of total gut bacteria compared to species that bind IgA, the scientists determined that without MyD88, IgA failed to recognize species that it can otherwise.

The work not only demonstrates that a balanced microbial community promotes digestive health, but that it also shapes the host’s immune system. Mice raised in a sterile, germ-free environment have a faulty immune system, a defect that can be fixed if they are fed bacterial components, TLR2 agonists, that activates the immune system. The rescue does not work in mice deficient for MyD88, demonstrating again that the protein is key to interpreting communications between microbes and the immune system.

“There is a conversation between our immune system and our resident bacteria,” explains Round. “The microbes can send signals that tell our immune system how to develop and in turn our immune system can shape what types of microbes live on our body.”

The dependency of host health on good bacteria has made the conversation a necessity. In response to demand, the immune system has adapted from a system designed to fight the body’s invaders to one that also nurtures a harmonious relationship with the body’s peaceful inhabitants.
 
MyD88 Signaling in T Cells Directs IgA-Mediated Control of the Microbiota to Promote Health. Jason L. Kubinak, Charisse Petersen, W. Zac Stephens, Ray Soto, Erin Bake, Ryan M. O’Connell and June L. Round. Cell Host and Microbe, Jan. 22, 2015

The work was supported by the National Institutes of Health, American Cancer Society, Edward Mallinckrodt Jr. Foundation, Sidney Kimmel Foundation, Pew Scholars Program, and Packard Fellowship in Science and Engineering